​Stephen R. Seiler

Founder & Chief Executive Officer

Board of Directors

 

Mr. Seiler is a biotechnology entrepreneur. Prior to joining Diceros Therapeutics, he was the founder and Chief Executive Officer of AesRx, LLC which focused on the development of a drug for sickle cell disease.  Mr. Seiler led the AesRx development program from lead molecule into Phase 2 at which point the company was acquired by Baxter International. He has been Chief Executive Officer of several other public and private biotech companies.  Previously Mr. Seiler was Executive Vice President, Planning, Investment & Development at Elan Corporation plc.  He was part of a senior management team that in 5 years transformed Elan from a small drug delivery company with annual revenues of $200 million into a fully integrated specialty pharmaceutical company with annual revenues $1.5 billion.  He has also worked as an Investment Banker in New York and London.

 

Mr. Seiler is a member of the Board of Associates of the Whitehead Institute for Biomedical Research.  He received a J.D. (Honors) from Georgetown University where he was an editor of the Georgetown Law Review.  He received his B.A., summa cum laude from the University of Notre Dame where he was also elected to Phi Beta Kappa.